Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Literature DB >> 1376518

Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

A Jain¹, R Venkataramanan, S Todo, K Abu-Elmagd, J Fung, V Warty, A Tzakis, J Reyes, M Alessiani, T E Starzl.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Tacrolimus

Year: 1992 PMID： 1376518 PMCID： PMC2957099

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

8 in total

1. Assay of FK 506 in plasma.

Authors: E M Cadoff; R Venkataramanan; A Krajack; A S Jain; J J Fung; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

2. Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

Authors: A B Jain; R Venkataramanan; E Cadoff; J J Fung; S Todo; A Krajack; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.

Authors: J M Armitage; R L Kormos; B P Griffith; R L Hardesty; F J Fricker; R S Stuart; G C Marrone; S Todo; J Fung; T E Starzl
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

4. Kidney transplantation under FK 506 immunosuppression.

Authors: R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

5. Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

Authors: R Venkataramanan; A Jain; V W Warty; K Abu-Elmagd; H Furakawa; O Imventarza; J Fung; S Todo; T E Starzl
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

6. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors: J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

7. A highly sensitive method to assay FK-506 levels in plasma.

Authors: K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

8. FK 506 for liver, kidney, and pancreas transplantation.

Authors: T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal: Lancet Date: 1989-10-28 Impact factor: 79.321

8 in total

6 in total

Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

1. Assay of FK 506 in plasma.

2. Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

3. A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.

4. Kidney transplantation under FK 506 immunosuppression.

5. Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

6. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

7. A highly sensitive method to assay FK-506 levels in plasma.

8. FK 506 for liver, kidney, and pancreas transplantation.

1. FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.

2. Is rejection a diffuse or localized process in small-bowel transplantation?

Review 3. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Review 4. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Review 5. Clinical pharmacokinetics of tacrolimus.

6. Tacrolimus trough levels before, during and after jejunostomy in a liver transplant patient: a case report.